Product NDC: | 67457-227 |
Proprietary Name: | Cosyntropin |
Non Proprietary Name: | cosyntropin |
Active Ingredient(s): | .25 mg/mL & nbsp; cosyntropin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67457-227 |
Labeler Name: | Mylan Institutional LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090574 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130508 |
Package NDC: | 67457-227-02 |
Package Description: | 10 VIAL in 1 CARTON (67457-227-02) > 1 mL in 1 VIAL (67457-227-00) |
NDC Code | 67457-227-02 |
Proprietary Name | Cosyntropin |
Package Description | 10 VIAL in 1 CARTON (67457-227-02) > 1 mL in 1 VIAL (67457-227-00) |
Product NDC | 67457-227 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cosyntropin |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20130508 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Institutional LLC |
Substance Name | COSYNTROPIN |
Strength Number | .25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenocorticotropic Hormone [Chemical/Ingredient],Adrenocorticotropic Hormone [EPC] |